Trial Profile
Experimental clinical open study, randomized, experimental group vs control group, for the evaluation of tolerability and the effects on magnetic resonance parameters and cognitive functions of memantine in patients at early stage of relapsing- remitting multiple sclerosis treated with interferon-beta.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2011
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms NEMESI-MS
- 23 Jul 2011 New trial record